EAACI guidelines on allergen immunotherapy-Out with the old and in with the new

Allergen manufacturing and quality aspects for allergen immunotherapy in Europe and the United States: An analysis from the EAACI AIT Guidelines Project

(2018) A. Bonertz et al.   ALLERGY

Results from the 5-year SQ grass sublingual immunotherapy tablet asthma prevention (GAP) trial in children with grass pollen allergy

(2018) Erkka Valovirta et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

EAACI guidelines on allergen immunotherapy: Prevention of allergy

(2017) Susanne Halken et al.   PEDIATRIC ALLERGY AND IMMUNOLOGY

International Consensus on Allergen Immunotherapy II: Mechanisms, standardization, and pharmacoeconomics

(2016) Marek Jutel et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Allergen immunotherapy for the prevention of allergy: A systematic review and meta-analysis

(2016) Maria Kristiansen et al.   PEDIATRIC ALLERGY AND IMMUNOLOGY

International consensus on allergy immunotherapy

(2015) Marek Jutel et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: an EAACI Position Paper

(2014) O. Pfaar et al.   ALLERGY

Long-term clinical efficacy in grass pollen–induced rhinoconjunctivitis after treatment with SQ-standardized grass allergy immunotherapy tablet

(2010) Stephen R. Durham et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY